DBC-664 in Adult Patients With Solid Tumors | MicrobiomeTrials← Back to trialsNCT07705035
DBC-664 in Adult Patients With Solid Tumors
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-07-17Est. Completion: 2030-04-01
Enrollment target: 210 participants Locations- Sarah Cannon Research Institute - Denver HealthONE, Denver, Colorado, United States
- START Midwest, Grand Rapids, Michigan, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- START New Jersey, East Brunswick, New Jersey, United States
- START New York, Lake Success, New York, United States
- SCRI Oncology Partners, Nashville, Tennessee, United States
- START San Antonio, San Antonio, Texas, United States
Other microbiome trials you might be interested in
5-aminolevulinic AcidFluorescence-guided ResectionHigh-Grade Glioma (WHO III-IV)
This phase III, multicenter, open-label, single-arm study will evaluate the ability of 5-aminolevulinic acid hydrochlori…
Guangzhou, ChinaEst. completion Dec 2027
Melanoma and Other Malignant Neoplasms of SkinBasal Cell Carcinoma of SkinSquamous Cell Carcinoma of the Skin
The goal of this clinical trial is to evaluate if the TruScore device can accurately diagnose suspicious skin lesions in…
Pleasanton, United StatesCompleted May 30, 2027